83 results
8-K
EX-99.2
ORTX
Orchard Therapeutics plc
10 Jan 22
Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene Therapy Programs and Outlines Key 2022 Milestones
7:05am
Bobby Gaspar, M.D., Ph.D., chief executive officer 40th Annual J.P. Morgan Healthcare Conference January 13, 2022 Reaching New Heights, Looking … to New Horizons Exhibit 99.2
2 | 40th Annual J.P. Morgan Healthcare Conference Photo courtesy of Great Ormond Street Hospital From Clinician to CEO
F-1
EX-10.1
ORTX
Orchard Therapeutics plc
3 Jun 19
Registration statement (foreign)
4:33pm
Exhibit 10.1
EXECUTION VERSION
DATED 2 August 2018
UNIQUE DIAMOND INVESTMENTS LIMITED (1)
F-PRIME CAPITAL PARTNERS HEALTHCARE FUND IV LP (2)
F … -PRIME CAPITAL PARTNERS HEALTHCARE FUNDIV-A LP (3)
SCOTTISH MORTGAGE INVESTMENT TRUST PLC (4)
TLS BETA PTE LTD (5)
COWEN HEALTHCARE INVESTMENTS II LP
F-1
EX-10.1
ORTX
Orchard Therapeutics plc
4 Oct 18
Registration statement (foreign)
4:48pm
Exhibit 10.1
EXECUTION VERSION
DATED 2 August 2018
UNIQUE DIAMOND INVESTMENTS LIMITED (1)
F-PRIME CAPITAL PARTNERS HEALTHCARE FUND IV LP (2)
F … -PRIME CAPITAL PARTNERS HEALTHCARE FUNDIV-A LP (3)
SCOTTISH MORTGAGE INVESTMENT TRUST PLC (4)
TLS BETA PTE LTD (5)
COWEN HEALTHCARE INVESTMENTS II LP
6-K
EX-99.1
ORTX
Orchard Therapeutics plc
7 Jan 19
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
8:02am
in conjunction with its attendance at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. Mark Rothera, president and chief executive officer … into the second half of 2020.
Presentation at 37th Annual J.P. Morgan Healthcare Conference
Orchard will webcast its corporate presentation from
6-K
ORTX
Orchard Therapeutics plc
7 Jan 19
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
8:02am
with investors attending the 37th Annual J.P. Morgan Healthcare Conference in San Francisco beginning on January 7, 2019. As part of these meetings, the Company … Presentation at the 37th Annual J.P. Morgan Healthcare Conference, dated January 7, 2019.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
8-K
EX-99.1
ns5wg1yrq lt49gx
13 Jan 20
Orchard Therapeutics Highlights 2020 Strategic Priorities
7:20am
DRS
m4l7rq n8h77
6 Aug 18
Draft registration statement
12:00am
8-K
EX-99.1
nrnm h8dypep1gs29z
3 Feb 20
Orchard Therapeutics Appoints Industry Veteran Steven Altschuler, M.D. to its Board of Directors
7:28am
20-F
st6dzo9
22 Mar 19
Annual report (foreign)
8:02am
424B4
hem2c0ilgb0 j9vyg
31 Oct 18
Prospectus supplement with pricing info
4:36pm
F-1/A
w6yl ytclso
23 Oct 18
Registration statement (foreign) (amended)
6:15am
10-K
ct66nswa3zig4
27 Feb 20
Annual report
4:02pm
F-1
v56823
4 Oct 18
Registration statement (foreign)
4:48pm
8-K
EX-99.1
p8x83vi8t in
31 Mar 20
Other Events
4:08pm
UPLOAD
h6ovc3uxksr
9 May 19
Letter from SEC
12:00am
8-K
EX-99.1
d349nvru9 vv
27 Feb 20
Orchard Therapeutics Reports 2019 Financial Results and Reviews Key Strategic Priorities for 2020
7:04am